Close

Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Buys]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $152.00 (+164.1%) * Over Last 12-Mos
Rating Score: 4.4 / 10   Percentile Rank: 45%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/4/2015 Wells Fargo N/A New Coverage Overweight
(N/A)
N/A
(N/A)
60.70
(57.56)
-5.17% Details
11/5/2015 Piper Sandler N/A Upgrade Overweight
(Neutral)
80.00
(64.00)
53.01
(57.56)
8.58% Details